Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.

Authors	J J Lokich
Journal	Cancer (Cancer) Vol. 82 Issue 5 Pg. 993 (Mar 01 1998) ISSN: 0008-543X [Print] United States
PMID	9486592 (Publication Type: Comment, Letter)
Chemical References	Antineoplastic Agents, Phytogenic Teniposide
Topics	Antineoplastic Agents, Phytogenic (therapeutic use) Carcinoma, Non-Small-Cell Lung (drug therapy) Clinical Trials, Phase II as Topic Humans Lung Neoplasms (drug therapy) Mathematical Computing Teniposide (therapeutic use) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!